Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial

Circulation: Cardiovascular Quality and Outcomes

Volumn 8, Issue 6, 2015, Pages 560-566

  Persell, Stephen D ^a,b   Brown, Tiffany ^a   Lee, Ji Young ^a,c   Shah, Shreya ^a,e   Henley, Eric ^a,f   Long, Timothy ^a,g,h   Luther, Stephanie ^a,d   Lloyd Jones, Donald M ^a,c,i   Jean Jacques, Muriel ^a   Kandula, Namratha R ^a,b   Sanchez, Thomas ^a,d   Baker, David W ^a,b  

^a Division of General Internal Medicine   (United States)

^b Institute for Public Health and Medicine   (United States)

^c Miriam and Rhode Island Hospitals   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f North Country HealthCare   (United States)

^g Near North Health Service Corporation   (United States)

^h Alliance of Chicago Community Health Services   (United States)

ⁱ Heartland Health Outreach Inc   (United States)

Author keywords

cardiovascular diseases; case management; cholesterol; randomized controlled trial; risk assessment

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH CARE PERSONNEL; HEALTH CENTER; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE BLIND PROCEDURE; AGED; ARIZONA; BLOOD; CARDIOVASCULAR DISEASES; CLINICAL PRACTICE; CLINICAL TRIAL; COMMUNITY CARE; COMPLICATION; DOCTOR PATIENT RELATION; DYSLIPIDEMIAS; ILLINOIS; INTERPERSONAL COMMUNICATION; MIDDLE AGED; MULTICENTER STUDY; ODDS RATIO; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIMARY PREVENTION; PROCEDURES; PROTOCOL COMPLIANCE; PUBLIC RELATIONS; RISK ASSESSMENT; STANDARDS; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AGED; ARIZONA; BIOMARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; COMMUNICATION; COMMUNITY HEALTH CENTERS; COMMUNITY HEALTH SERVICES; COMMUNITY-INSTITUTIONAL RELATIONS; DYSLIPIDEMIAS; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ILLINOIS; MALE; MIDDLE AGED; ODDS RATIO; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS; SINGLE-BLIND METHOD; TIME FACTORS; TREATMENT OUTCOME;

EID: 84947725480     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.115.001723     Document Type: Article

References (27)

1. Cholesterol Treatment Trialists Collaborators, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, Baigent C. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-Analysis of individual data from 27 randomised trials. Lancet. 2012;380:581-590.
2. Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1:CD004816. doi: 10.1002/14651858.CD004816.pub5.
3. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 suppl 2):S1-S45. doi: 10.1161/01.cir.0000437738.63853.7a.
4. Qato DM, Lindau ST, Conti RM, Schumm LP, Alexander GC. Racial and ethnic disparities in cardiovascular medication use among older adults in the United States. Pharmacoepidemiol Drug Saf. 2010;19:834-842. doi: 10.1002/pds.1974.
5. Ma J, Sehgal NL, Ayanian JZ, Stafford RS. National trends in statin use by coronary heart disease risk category. PLoS Med. 2005;2:e123. doi: 10.1371/journal.pmed.0020123.
6. Ritchey MD, Wall HK, Gillespie C, George MG, Jamal A; Division for Heart Disease and Stroke Prevention, CDC. Million hearts: prevalence of leading cardiovascular disease risk factors-United States, 2005-2012. MMWR Morb Mortal Wkly Rep. 2014;63:462-467.
7. Ford ES, Li C, Pearson WS, Zhao G, Mokdad AH. Trends in hypercholesterolemia, treatment and control among United States adults. Int J Cardiol. 2010;140:226-235. doi: 10.1016/j.ijcard.2008.11.033.
8. Centers for Disease C, Prevention. Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol-United States, 1999-2002 and 2005-200. MMWR Morb Mortal Wkly Rep. 2011;60:109-114.
9. Franks P, Tancredi D, Winters P, Fiscella K. Cholesterol treatment with statins: who is left out and who makes it to goal? BMC Health Serv Res. 2010;10:68. doi: 10.1186/1472-6963-10-68.
10. Persell SD, Zei C, Cameron KA, Zielinski M, Lloyd-Jones DM. Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: A primary care physician survey. Arch Intern Med. 2010;170:470-477. doi: 10.1001/archinternmed.2009.525.
11. Sekaran NK, Sussman JB, Xu A, Hayward RA. Providing clinicians with a patients 10-year cardiovascular risk improves their statin prescribing: A true experiment using clinical vignettes. BMC Cardiovasc Disord. 2013;13:90. doi: 10.1186/1471-2261-13-90.
12. Green BB, Anderson ML, Cook AJ, Catz S, Fishman PA, McClure JB, Reid R. Using body mass index data in the electronic health record to calculate cardiovascular risk. Am J Prev Med. 2012;42:342-347. doi: 10.1016/j.amepre.2011.12.009.
13. Van Wyk JT, Van Wijk MA. Assessment of the possibility to classify patients according to cholesterol guideline screening criteria using routinely recorded electronic patient record data. Stud Health Technol Inform. 2002;93:39-46.
14. Persell SD, Dunne AP, Lloyd-Jones DM, Baker DW. Electronic health record-based cardiac risk assessment and identification of unmet preventive needs. Med Care. 2009;47:418-424. doi: 10.1097/MLR.0b013e31818dce21.
15. Persell SD, Lloyd-Jones DM, Friesema EM, Cooper AJ, Baker DW. Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: A cluster randomized trial. J Gen Intern Med. 2013;28:554-560. doi: 10.1007/s11606-012-2268-1.
16. Siegel B, Sears V, Bretsch JK, Wilson M, Jones KC, Mead H, Hasnain-Wynia R, Ayala RK, Bhalla R, Cornue CM, Emrich CM, Patel P, Setzer JR, Suitonu J, Velazquez EJ, Eagle KA, Winniford MD. A quality improvement framework for equity in cardiovascular care: results of a national collaborative. J Healthc Qual. 2012;34:32-42; quiz 42. doi: 10.1111/j.1945-1474.2011.00196.x.
17. Hasnain-Wynia R, Baker DW, Nerenz D, Feinglass J, Beal AC, Landrum MB, Behal R, Weissman JS. Disparities in health care are driven by where minority patients seek care: examination of the hospital quality alliance measures. Arch Intern Med. 2007;167:1233-1239. doi: 10.1001/archinte.167.12.1233.
18. The Framingham Heart Study. Hard coronary heart disease (10-year risk). https://www.framinghamheartstudy.org/risk-functions/coronary-heartdisease/hard-10-year-risk.php. Accessed 11 September 2014.
19. U. S. Preventive Services Task Force. Final Recommendation Statement: Lipid Disorders in Adults (Cholesterol, Dysplipidemia): Screening. U. S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce. org/uspstf08/lipid/lipidrs.htm. Accessed 11 September, 2014.
20. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
21. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004;44:720-732. doi: 10.1016/j. jacc.2004.07.001.
22. DAgostino RB , Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation. 2008;117:743-753. doi: 10.1161/CIRCULATIONAHA.107.699579.
23. Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, Weissman JS. Primary medication non-Adherence: Analysis of 195, 930 electronic prescriptions. J Gen Intern Med. 2010;25:284-290. doi: 10.1007/s11606-010-1253-9.
24. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-Term persistence in use of statin therapy in elderly patients. JAMA. 2002;288:455-461.
25. Sheridan SL, Viera AJ, Krantz MJ, Ice CL, Steinman LE, Peters KE, Kopin LA, Lungelow D; Cardiovascular Health Intervention Research and Translation Network Work Group on Global Coronary Heart Disease Risk. The effect of giving global coronary risk information to adults: A systematic review. Arch Intern Med. 2010;170:230-239. doi: 10.1001/archinternmed.2009.516.
26. Sheridan SL, Draeger LB, Pignone MP, Keyserling TC, Simpson RJ Jr, Rimer B, Bangdiwala SI, Cai J, Gizlice Z. A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies. BMC Health Serv Res. 2011;11:331. doi: 10.1186/1472-6963-11-331.
27. Keyserling TC, Sheridan SL, Draeger LB, Finkelstein EA, Gizlice Z, Kruger E, Johnston LF, Sloane PD, Samuel-Hodge C, Evenson KR, Gross MD, Donahue KE, Pignone MP, Vu MB, Steinbacher EA, Weiner BJ, Bangdiwala SI, Ammerman AS. A comparison of live counseling with a web-based lifestyle and medication intervention to reduce coronary heart disease risk: A randomized clinical trial. JAMA Intern Med. 2014;174:1144-1157. doi: 10.1001/jamainternmed.2014.1984.